Neuromuscular paralysis for newborn infants receiving mechanical ventilation

Area of Science:

• Neonatal care
• Pediatric critical care
• Respiratory support

Background:

• Newborn infants on mechanical ventilation may experience complications from breathing asynchrony.
• Neuromuscular paralysis can eliminate spontaneous breathing but carries potential risks.
• Concerns exist regarding the safety of prolonged neuromuscular paralysis in neonates.

Purpose of the Study:

• To evaluate the benefits and harms of routine neuromuscular paralysis in mechanically ventilated newborn infants.
• To compare routine paralysis versus no routine paralysis in this population.

Main Methods:

• Systematic review of randomized controlled trials (RCTs) identified through MEDLINE, EMBASE, and Cochrane Controlled Trials Register.
• Included trials compared routine neuromuscular blocking agents with no or selective paralysis in ventilated newborns.
• Methodological quality was assessed independently; data synthesized using relative risk and weighted mean difference.

Main Results:

• Five RCTs involving preterm infants with respiratory distress syndrome using pancuronium were included.
• Neuromuscular paralysis showed a significant reduction in intraventricular hemorrhage (IVH) in infants with asynchronous breathing.
• No significant differences were found in mortality, air leak, or chronic lung disease across all trials.

Conclusions:

• Pancuronium may be beneficial for reducing IVH and possibly air leak in preterm infants with asynchronous respiratory efforts.
• Long-term pulmonary and neurological effects, and safety of prolonged paralysis remain uncertain.
• Routine use of pancuronium or other neuromuscular blocking agents is not recommended due to insufficient evidence.